Reserpine indications and usage: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AK}} | {{CMG}}; {{AE}} {{AK}} | ||
== | ==Indications And Usage== | ||
Mild essential hypertension; also useful as adjunctive therapy with other [[antihypertensive ]]agents in the more severe forms of hypertension; relief of symptoms in agitated psychotic states (e.g., [[schizophrenia]]), primarily in those individuals unable to tolerate [[phenothiazine ]]derivatives or in those who also require [[antihypertensive ]]medication.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = RESERPINE TABLET [EON LABS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a4d74d7-2e63-4789-b50e-af17ced92462 | publisher = | date = | accessdate = 7 March 2014 }}</ref> | Mild essential hypertension; also useful as adjunctive therapy with other [[antihypertensive ]]agents in the more severe forms of hypertension; relief of symptoms in agitated psychotic states (e.g., [[schizophrenia]]), primarily in those individuals unable to tolerate [[phenothiazine ]]derivatives or in those who also require [[antihypertensive ]]medication.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = RESERPINE TABLET [EON LABS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a4d74d7-2e63-4789-b50e-af17ced92462 | publisher = | date = | accessdate = 7 March 2014 }}</ref> |
Revision as of 17:48, 12 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Indications And Usage
Mild essential hypertension; also useful as adjunctive therapy with other antihypertensive agents in the more severe forms of hypertension; relief of symptoms in agitated psychotic states (e.g., schizophrenia), primarily in those individuals unable to tolerate phenothiazine derivatives or in those who also require antihypertensive medication.[1]
References
- ↑ "RESERPINE TABLET [EON LABS, INC.]". Retrieved 7 March 2014.